![Molina Healthcare Inc](/common/images/company/NY_MOH.png)
Molina Healthcare Inc offers healthcare plans focused on Medicaid-related solutions for low-income families and individuals. Its health plans are operated by a network of subsidiaries, each of which is licensed as a health maintenance organization (HMO). In addition to its Health Plans segment, Moli... Molina Healthcare Inc offers healthcare plans focused on Medicaid-related solutions for low-income families and individuals. Its health plans are operated by a network of subsidiaries, each of which is licensed as a health maintenance organization (HMO). In addition to its Health Plans segment, Molina has a Medicaid Solutions segment that provides solutions to U.S. state governments for their Medicaid management information systems. Molina's Medicaid plans receive revenue on a per-member per-month basis from state government agencies, and its Medicare Advantage plans receive revenue from managed care plans that contract with the Centers for Medicaid and Medicare (CMS). Molina also provides plans through health insurance exchanges. Show more
MINDBIO THERAPEUTICS BEGINS DOSING MB22001 IN PHASE 2 CLINICAL TRIAL IN WORLD FIRST TAKE-HOME MICRODOSING STUDY IN PATIENTS WITH DEPRESSION World-first take-home approvals...
MINDBIO THERAPEUTICS BREAKTHROUGH DISCOVERY IN MICRODOSING CLINICAL TRIAL REVEALS SIGNIFICANT POSITIVE EFFECTS ON QUALITY OF SLEEPNew Discovery: MindBio's LSD-Microdosing Treatment Improves...
MINDBIO THERAPEUTICS CEO DEMONSTRATES HOW 1 MILLION MICRODOSES OF LSD CAN POTENTIALLY BE USED TO TREAT DEPRESSION 1 Million Microdoses used to create proprietary microdosing...
ETHICS APPROVAL FOR LANDMARK WORLD FIRST PHASE 2 CLINICAL TRIAL OF TAKE-HOME LSD-MICRODOSING FOR MAJOR DEPRESSIVE DISORDEREthics approval received for take-home LSD-Microdosing clinical...
PHASE 2 CLINICAL TRIAL HAS RECEIVED ETHICS APPROVAL FOR WORLD FIRST TAKE-HOME LSD-MICRODOSING TRIALS IN CANCER PATIENTS EXPERIENCING EMOTIONAL DISTRESSEthics approval granted The clinical trial...
MindBio Therapeutics Corp (CSE: MBIO) Reveals Scientific Paper in World-First Take-Home, LSD-Microdosing Clinical Trial in 80 Healthy Participants MindBio clinical trial...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 61.6 | 21.5497638622 | 285.85 | 351.47 | 285.81 | 1459750 | 325.28175181 | CS |
4 | 55.22 | 18.8960750094 | 292.23 | 351.47 | 282.96 | 863038 | 307.05946628 | CS |
12 | -4.74 | -1.34586444817 | 352.19 | 355.67 | 282.96 | 623415 | 312.17298599 | CS |
26 | -10.05 | -2.81118881119 | 357.5 | 423.9244 | 282.96 | 501758 | 341.16649012 | CS |
52 | 45.37 | 15.0192002119 | 302.08 | 423.9244 | 282.96 | 431940 | 342.61378994 | CS |
156 | 74.55 | 27.3176987908 | 272.9 | 423.9244 | 244.75 | 444021 | 317.32084955 | CS |
260 | 204.45 | 142.972027972 | 143 | 423.9244 | 102.85 | 460597 | 253.69768319 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.